Registrants1
Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.
918596198
Manufacturing Establishments1
FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.
Zydus Lifesciences Limited
Zydus Lifesciences Limited
918596198
Products1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Risedronate Sodium
Product Details
Drug Labeling Information
Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
NDC 70771-1436-4 in blister-carton of 4 (1 x 4) Unit-dose Tablets
Risedronate Sodium Delayed-release Tablets, 35 mg
Rx only
4 Tablets
